4//SEC Filing
Peraza Lisa 4
Accession 0001209191-24-001626
CIK 0000818033other
Filed
Jan 15, 7:00 PM ET
Accepted
Jan 16, 5:19 PM ET
Size
13.2 KB
Accession
0001209191-24-001626
Insider Transaction Report
Form 4
Peraza Lisa
VP, Chief Accounting Officer
Transactions
- Tax Payment
Common Stock
2024-01-13$2.15/sh−756$1,625→ 55,907 total - Exercise/Conversion
Restricted Stock Units
2024-01-13−1,289→ 6,675 total→ Common Stock (1,289 underlying) - Exercise/Conversion
Common Stock
2024-01-13+552→ 55,374 total - Exercise/Conversion
Common Stock
2024-01-13+1,289→ 56,663 total - Exercise/Conversion
Restricted Stock Units
2024-01-13−552→ 1,656 total→ Common Stock (552 underlying)
Footnotes (4)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions.
- [F3]The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).
- [F4]The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021).
Documents
Issuer
HERON THERAPEUTICS, INC. /DE/
CIK 0000818033
Entity typeother
Related Parties
1- filerCIK 0001828266
Filing Metadata
- Form type
- 4
- Filed
- Jan 15, 7:00 PM ET
- Accepted
- Jan 16, 5:19 PM ET
- Size
- 13.2 KB